Stifel Financial
NVAX icon

Stifel Financial’s Novavax NVAX Stock Holding History

Stifel Financial’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,961
Closed -$218K – 3425
2022
Q1 		$218K Buy
2,961
+395
+15% +$35.2K ﹤0.01% 3070
2021
Q4 		$367K Sell
2,566
-1,309
-34% -$225K ﹤0.01% 2786
2021
Q3 		$804K Buy
3,875
+402
+12% +$88.6K ﹤0.01% 2259
2021
Q2 		$738K Buy
3,473
+645
+23% +$118K ﹤0.01% 2332
2021
Q1 		$512K Sell
2,828
-1,331
-32% -$265K ﹤0.01% 2472
2020
Q4 		$464K Buy
4,159
+667
+19% +$70.9K ﹤0.01% 2371
2020
Q3 		$378K Buy
+3,492
New +$425K ﹤0.01% 2258
2016
Q3 		– Sell
-1,100
Closed -$160K – 2468
2016
Q2 		$160K Buy
1,100
+20
+2% +$2.29K ﹤0.01% 2311
2016
Q1 		$112K Hold
1,080
– – ﹤0.01% 2094
2015
Q4 		$181K Buy
+1,080
New +$166K ﹤0.01% 2144

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Stifel Financial's NVAX Position: Q2 2022 in Review

Stifel Financial sold out of Novavax (NVAX) in Q2 2022, closing a stake of 2,961 shares — an estimated $218K sold.

Stifel Financial first reported a position in NVAX in Q4 2015 and held it in 10 quarters. The position peaked at $804K in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Stifel Financial reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Stifel Financial sold 2,961 Novavax shares in Q2 2022, an estimated $218K.
  • Stifel Financial first reported a position in Novavax in Q4 2015 and held it in 10 quarters.
  • Stifel Financial's Novavax position peaked at $804K in Q3 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Stifel Financial's 13F filing for Q2 2022, filed 15 Aug 2022.